Ultimate success in epilepsy - The patient's perspective

European Journal of Neurology, Supplement

Volumn 12, Issue 4, 2005, Pages 3-11

  Sander, Josemir W ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b EPILEPSY SOCIETY   (United Kingdom)

Author keywords

Antiepileptic drugs; Comorbidities; Epilepsy; Psychosocial costs; Quality of life; Sleep disturbances

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; MOOD STABILIZER; OXCARBAZEPINE; PHENYTOIN; PREGABALIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

APPETITE DISORDER; BIRTH DEFECT; CELL DAMAGE; COGNITION; COGNITIVE DEFECT; CONFERENCE PAPER; DEPRESSION; DISEASE EXACERBATION; DIZZINESS; DRUG TOLERABILITY; EPILEPSY; FEAR; HAIR LOSS; HEADACHE; HUMAN; HYPERACTIVITY; INSOMNIA; LIVER INJURY; MEMORY DISORDER; MOOD DISORDER; NAUSEA; NEUROPSYCHOLOGY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PSYCHIATRY; QUALITY OF LIFE; RASH; SEIZURE; SEXUAL DYSFUNCTION; SIDE EFFECT; SLEEP DISORDER; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT; SOMNOLENCE; TREMOR; VISUAL IMPAIRMENT; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 27744531777     PISSN: 14710552     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2005.01326.x     Document Type: Conference Paper

References (65)

1. Aldenkamp AP, van Donselaar C (2003). Treatment of epilepsy in general hospitals: do patients and neurologists agree on success or failure? Seizure 12:523-528.
2. Aldenkamp AP, van Donselaar CA, Flamman H, Lafarre DL (2003). Psychosocial reactions to the epilepsy in an unselected group of patients with epilepsy under treatment in general hospitals. Seizure 12:101-106.
3. Austin JK, Osborne Shafer P, Beach Deering J (2002). Epilepsy familiarity, knowledge, and perceptions of stigma: report from a survey of adolescents in the general population. Epilepsy Behav 3:368-375.
4. Baker GA, Jacoby A, Buck D, Stalgis C, Monnet D (1997). Quality of life of people with epilepsy: a European study. Epilepsia 38:353-362.
5. Baker GA, Brooks J, Buck D, Jacoby A (1999). The stigma of epilepsy: a European perspective. Epilepsia 41:98-104.
6. Bazil CW (2002). Sleep and epilepsy. Semin Neurol 22:321-327.
7. Bazil CW (2003). Sleep-related epilepsy. Curr Neurol Neurosci Rep 3:167-172.
8. Berg AT, Engel J Jr (1999). Restricted driving for people with epilepsy. Neurology 52:1306-1307.
9. Bootsma HPR, Coolen F, Aldenkamp AP et al. (2004). Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center. Epilepsy Behav 5:380-387.
10. Bowden CL, Calabrese JR, Sachs G et al. (2003). A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 60:392-400.
11. Boylan LS, Flint LA, Labovitz DL, Jackson SC, Starner K, Devinsky O (2004). Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy. Neurology 62:258-261.
12. Brent DA, Crumrine PK, Varma RR, Allan M, Allman C (1987). Phenobarbital treatment and major depressive disorder in children with epilepsy. Pediatrics 80:909-917.
13. Brodie MJ, Dichter MA (1996). Antiepileptic drugs. N Engl J Med 334:168-175.
14. Chaplin JE, Wester A, Tomson T (1998). Factors associated with the employment problems of people with established epilepsy. Seizure 7:299-303.
15. Collings JA (1990). Psychosocial well-being and epilepsy: an empirical study. Epilepsia 31:418-426.
16. Devinsky O (2004). Therapy for neurobehavioral disorders in epilepsy. Epilepsia 45(Suppl. 2):34-40.
17. Dodrill CB (2004). Neuropsychological effects of seizures. Epilepsy Behav 5(Suppl. 1):21-24.
18. van Dongen HPA, Maislin G, Mullington JM, Dinges DF (2003). The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep 26:117-126.
19. Edwards KR, Sackellares JC, Vuong A, Hammer AE, Barrett PS (2001). Lamotrigine monotherapy improves depressive symptoms in epilepsy: a double-blind comparison with valproate. Epilepsy Behav 2:28-36.
20. Feltner DE, Crockall JG, Dubovsky SJ et al. (2003). A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder. J Clin Psychopharmacol 23:240-249.
21. Fisher RS, Vickrey BG, Gibson P et al. (2000a). The impact of epilepsy from the patient's perspective I. Descriptions and subjective perceptions. Epilepsy Res 41:39-51.
22. Fisher RS, Vickrey BG, Gibson P et al. (2000b). The impact of epilepsy from the patient's perspective II: views about therapy and health care. Epilepsy Res 41:53-61.
23. Garcia-Borreguero D, Larrosa O, la Llave et al. (2002). Treatment of restless legs syndrome with gabapentin: a double-blind, crossover study. Neurology 59:1573-1579.
24. Ghaemi SN, Berv DA, Klugman J, Rosenquist KJ, Hsu DJ (2003). Oxcarbazepine treatment of bipolar disorder. J Clin Psychiatry 64:943-945.
25. Gilliam F (2002). Optimizing health outcomes in active epilepsy. Neurology 58(Suppl. 5):9-19.
26. Gilliam FG (2005). Epilepsy - success in clinical practice: translating trials to practice. Eur J Neurol 12(Suppl. 4):22-29.
27. Gilliam F, Kanner AM (2002). Treatment of depressive disorders in epilepsy patients. Epilepsy Behav 3(Suppl. 5):2-9.
28. Gilliam F, Kuzniecky R, Faught E, Black L, Carpenter G, Schrodt R (1997). Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia 38:233-236.
29. Goldstein MA, Harden CL (2000). Epilepsy and anxiety. Epilepsy Behav 1:228-234.
30. Harden CL, Goldstein MA (2002). Mood disorders in patients with epilepsy: epidemiology and management. CNS Drugs 16:291-302.
31. Hayden M, Penna C, Buchanan N (1992). Epilepsy: patient perceptions of their condition. Seizure 1:191-197.
32. van Hout B, Gagnon D, Souêtre E et al. (1997). Relationship between seizure frequency and costs and quality of life of outpatients with partial epilepsy in France, Germany, and the United Kingdom. Epilepsia 38:1221-1226.
33. Jacoby A (1992). Epilepsy and the quality of everyday life: findings from a study of people with well-controlled epilepsy. Soc Sci Med 34:657-666.
34. Jacoby A (1995). Impact of epilepsy on employment status: findings from a UK study of people with well-controlled epilepsy. Epilepsy Res 21:125-132.
35. Kanner AM (2000). Psychosis of epilepsy: a neurologist's perspective. Epilepsy Behav 1:219-227.
36. Kanner AM, Balabanov A (2002). Depression and epilepsy: how closely related are they? Neurology 58(Suppl. 5):27-39.
37. Kasper S, Blagden M, Seghers S et al. (2002). A placebo-controlled study of pregabalin and venlafaxine treatment of GAD. Poster presented at: Annual Meeting of the American Psychiatric Association; May 21, 2002, Philadelphia, PA.
38. Kwan P, Brodie MJ (2001a). Effectiveness of first antiepileptic drug. Epilepsia 42:1255-1260.
39. Kwan P, Brodie MJ (2001b). Neuropsychological effects of epilepsy and antiepileptic drugs. Lancet 357:216-222.
40. Lee S, Sziklas V, Andermann F et al. (2003). The effects of adjunctive topiramate on cognitive function in patients with epilepsy. Epilepsia 44:339-347.
41. Lehrner J, Kalchmayr R, Series W et al. (1999). Health-related quality of life (HRQOL), activity of daily living (ADL) and depressive mood disorder in temporal lobe epilepsy patients. Seizure 8:88-92.
42. Leidy NK, Elixhauser A, Vickrey B, Means E, Willian MK (1999). Seizure frequency and the health-related quality of life of adults with epilepsy. Neurology 53:162-166.
43. Malow BA, Levy K, Maturen K, Bowes R (2000). Obstructive sleep apnea is common in medically refractory epilepsy patients. Neurology 55:1002-1007.
44. Manni R, Terzaghi M, Arbasino C, Sartori I, Galimberti CA, Tartara A (2003). Obstructive sleep apnea in a clinical series of adult epilepsy patients: frequency and features of the comorbidity. Epilepsia 44:836-840.
45. Maquet P (2001). The role of sleep in learning and memory. Science 294:1048-1052.
46. Marson AG, Kadir ZA, Hutton JL, Chadwick DW (1997). The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia 38:859-880.
47. Martin R, Kuzniecky R, Ho S et al. (1999). Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology 52:321-327.
48. McElroy SL, Zarate CA, Coojkson J et al. (2004). A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression. J Clin Psychiatry 65:204-210.
49. Mendez M, Radtke RA (2001). Interactions between sleep and epilepsy. J Clin Neurophysiol 18J106-127.
50. Moran NF, Poole K, Bell G et al. (2004). Epilepsy in the United Kingdom: seizure frequency and severity, anti-epileptic drug utilization and impact on life in 1652 people with epilepsy. Seizure 13:425-433.
51. Pande AC, Davidson JRT, Jefferson JW et al. (1999). Treatment of social phobia with gabapentin: a placebo-controlled study. J Clin Psychopharmacol 19:341-348.
52. Pande AC, Crockatt JG, Janney CA, Werth JL, Tsaroucha G (2000). Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Bipolar Disord 2:249-255.
53. Pande AC, Crockatt JG, Feltner DE et al. (2003). Pregabalin in generalized anxiety disorder: a placebo-controlled trial. Am J Psychiatry 160:1-8.
54. Perrine K, Hermann BP, Meador KJ et al. (1995). The relationship of neuropsychologicjal functioning to quality of life in epilepsy. Arch Neurol 52:997-1003.
55. Post RM, Ketter TA, Denicoff K et al. (1996). The place of anticonvulsant therapy in bipolar illness. Psychopharmacology 128:115-129.
56. Pulliainen V, Kuikka P, Jokelainen M (2000). Motor and cognitive function in newly diagnosed adult seizure patients before antiepileptic medication. Acta Neurol Scand 101:73-78.
57. Rosenthal M (2003). Tiagabine for the treatment of generalized anxiety disorder: a randomized, open-label, clinical trial with paroxetine as a positive control. J Clin Psychiatry 64:1245-1249.
58. Sander JWAS (1993). Some aspects of prognosis in the epilepsies: a review. Epilepsia 34:1007-1016.
59. Schmidt D, Gram L (1995). Monotherapy versus polytherapy in epilepsy: a reappraisal. CNS Drugs 3:194-208.
60. Scicutella A, Ettinger AB (2002). Treatment of anxiety in epilepsy. Epilepsy Behav 3(Suppl. 5):10-12.
61. Stavem K, Loge JH, Kaasa S (2000). Health status of people with epilepsy compared with a general reference population. Epilepsia 41:85-90.
62. Stickgold R, Hobson JA, Fosse R, Fosse M (2001). Sleep, learning, and dreams: off-line memory reprocessing. Science 294:1052-1057.
63. Szaflarski JP, Szaflarski M (2004), Seizure disorders, depression, and health-related quality of life. Epilepsy Behav 5:50-57.
64. Thompson PJ, Shorvon SD, Heanqy D (1999). The Epilepsies. In: Greenwood RJ, Barnes MP, McMillan TM, Ward CD, eds. Handbook of Neurological Rehabilitation. Psychology Press pg., Howe, pp. 505-522.
65. de Weerd A, de Haas S, Otte A et al. (2004). Subjective sleep disturbance in patients with partial epilepsy: a questionnaire-based study on prevalence and impact on quality of life. Epilepsia 45:1397-1404.